rs1217691063
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Fasting venous blood samples from each participant were analyzed for plasma homocysteine and the C677T MTHFR gene mutation.
|
19142139 |
2009 |
rs1217691063
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Bilateral transverse sinus thrombosis secondary to a homozygous C677T MTHFR gene mutation.
|
18666857 |
2008 |
rs1217691063
|
|
|
0.100 |
GeneticVariation |
BEFREE |
In contrast, factor V Leiden, the G20210A prothrombin gene mutation, and the C677T MTHFR gene mutation are not genetic risk factors among Thai patients with VTE.
|
18192106 |
2007 |
rs1217691063
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The C677T methylenetetrahydrofolate reductase gene mutation does not influence cardiovascular risk in the dialysis population: results of a multicentre prospective study.
|
15618240 |
2005 |
rs1217691063
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Odds ratio for the probability of the C677T MTHFR gene mutation in the patients versus control group was 22.29 (95% CI 4.89-98.8).
|
15613145 |
2005 |
rs1217691063
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus.
|
14737040 |
2004 |
rs1217691063
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The C677T MTHFR gene mutation was determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in 640 subjects, residents of the Zagreb city or Zagreb surroundings.
|
12927690 |
2003 |
rs1217691063
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Patients with late-onset depression had an increased rate of the C677T MTHFR gene mutation and other vascular risk factors.
|
11722155 |
2001 |
rs1217691063
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Odds ratios for the probability of the C677T MTHFR gene mutation in the patient versus control group were 0.49 (95% CI 0.21-1.12).
|
11014892 |
2000 |
rs1217691063
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The C677T methylenetetrahydrofolate reductase gene mutation in hemodialysis patients.
|
10770966 |
2000 |
rs1217691063
|
|
|
0.100 |
GeneticVariation |
BEFREE |
In all of the subjects, we evaluated total homocysteine and thrombomodulin plasma levels and the distribution of the C677T methylenetetrahydrofolate reductase gene mutation.
|
10957660 |
2000 |
rs1217691063
|
|
|
0.100 |
GeneticVariation |
BEFREE |
In addition, combined prothrombotic defects were found in a further 10 patients: the FV mutation was combined with the prothrombin G20210A variant (n = 1), increased Lp(a) (n = 3), protein C deficiency (n = 1), and homozygosity for the C677T MTHFR gene mutation (n = 1).
|
10029588 |
1999 |
rs1217691063
|
|
|
0.100 |
GeneticVariation |
BEFREE |
The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss.
|
10233370 |
1999 |
rs1217691063
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Individuals with the thermolabile variant of methylenetetrahydrofolate reductase (MTHFR), due to homozygous C677T MTHFR gene mutation, have significantly raised plasma levels of homocysteine and may be at increased risk of vascular disease.
|
10477457 |
1999 |
rs201891426
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In all of the subjects, we evaluated total homocysteine and thrombomodulin plasma levels and the distribution of the C677T methylenetetrahydrofolate reductase gene mutation.
|
10957660 |
2000 |
rs1188383936
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In addition, combined prothrombotic defects were found in a further 10 patients: the FV mutation was combined with the prothrombin G20210A variant (n = 1), increased Lp(a) (n = 3), protein C deficiency (n = 1), and homozygosity for the C677T MTHFR gene mutation (n = 1).
|
10029588 |
1999 |